EG18596A - Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility - Google Patents

Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility

Info

Publication number
EG18596A
EG18596A EG602/88A EG60288A EG18596A EG 18596 A EG18596 A EG 18596A EG 602/88 A EG602/88 A EG 602/88A EG 60288 A EG60288 A EG 60288A EG 18596 A EG18596 A EG 18596A
Authority
EG
Egypt
Prior art keywords
fertility
useful
preparation
control
peptide structure
Prior art date
Application number
EG602/88A
Other languages
English (en)
Original Assignee
Lafon Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Pharma filed Critical Lafon Pharma
Application granted granted Critical
Publication of EG18596A publication Critical patent/EG18596A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EG602/88A 1987-11-26 1988-11-27 Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility EG18596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716420A FR2623715B1 (fr) 1987-11-26 1987-11-26 Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite

Publications (1)

Publication Number Publication Date
EG18596A true EG18596A (en) 1993-07-30

Family

ID=9357207

Family Applications (1)

Application Number Title Priority Date Filing Date
EG602/88A EG18596A (en) 1987-11-26 1988-11-27 Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility

Country Status (22)

Country Link
US (1) US5496551A (de)
EP (1) EP0323769B1 (de)
JP (1) JP2509312B2 (de)
KR (1) KR890008171A (de)
CN (1) CN1034208A (de)
AP (1) AP71A (de)
AT (1) ATE102957T1 (de)
AU (1) AU617716B2 (de)
DE (1) DE3888509T2 (de)
DK (1) DK660888A (de)
EG (1) EG18596A (de)
ES (1) ES2052762T3 (de)
FR (1) FR2623715B1 (de)
IE (1) IE883545L (de)
IL (1) IL88381A (de)
MA (1) MA21448A1 (de)
NO (1) NO885231L (de)
NZ (1) NZ227073A (de)
OA (1) OA08971A (de)
PT (1) PT89053B (de)
TN (1) TNSN88129A1 (de)
ZA (1) ZA888733B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9001709A (nl) * 1990-07-27 1992-02-17 Stichting Centr Diergeneeskund Peptiden en farmaceutische preparaten met een glycoprotene hormoon agonistische of antagonistische werking.
FR2710845B1 (fr) * 1993-10-08 1996-03-29 Lafon Labor Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
FR2702494B1 (fr) * 1993-03-11 1995-06-09 Lafon Labor Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
WO1994020859A1 (fr) * 1993-03-11 1994-09-15 Laboratoire L. Lafon TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
KR20010083126A (ko) * 1998-07-23 2001-08-31 피터 지. 스트링거 여포자극 호르몬 및 여포자극 호르몬 변이체 제형, 제품및 방법
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
WO2026006438A1 (en) * 2024-06-26 2026-01-02 The Regents Of The University Of California Non-surgical, injectable sterilant for dogs and cats

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
DK159276C (da) * 1980-03-31 1991-02-18 Takeda Chemical Industries Ltd Fremgangsmaade til isolering af specifikke antistoffer og enzym-immunbestemmelsesmetode med anvendelse af det isolerede antistof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0142387A1 (de) * 1983-08-26 1985-05-22 Anda Biologicals Verfahren zur Herstellung von spezifischen Impfstoffen für LH und HCG und Verfahren für ihre Entdeckung
EP0224574A4 (de) * 1985-06-04 1988-04-26 Biotech Res Partners Ltd Autoantigene impfstoffe.
CA1239346A (en) * 1985-06-04 1988-07-19 National Institute Of Immunology Birth control vaccine
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides

Also Published As

Publication number Publication date
DE3888509D1 (de) 1994-04-21
FR2623715A1 (fr) 1989-06-02
ZA888733B (en) 1990-08-29
AP8800110A0 (en) 1989-01-31
NO885231D0 (no) 1988-11-24
TNSN88129A1 (fr) 1990-07-10
NZ227073A (en) 1990-06-26
KR890008171A (ko) 1989-07-10
EP0323769A1 (de) 1989-07-12
EP0323769B1 (de) 1994-03-16
AU617716B2 (en) 1991-12-05
JP2509312B2 (ja) 1996-06-19
CN1034208A (zh) 1989-07-26
MA21448A1 (fr) 1989-07-01
AP71A (en) 1990-02-24
OA08971A (fr) 1990-11-30
PT89053A (pt) 1988-12-01
NO885231L (no) 1989-05-29
ES2052762T3 (es) 1994-07-16
IL88381A (en) 1993-03-15
DE3888509T2 (de) 1994-10-06
US5496551A (en) 1996-03-05
FR2623715B1 (fr) 1990-12-21
IL88381A0 (en) 1989-06-30
JPH01301696A (ja) 1989-12-05
AU2596888A (en) 1989-06-01
IE883545L (en) 1989-05-26
DK660888A (da) 1989-05-27
ATE102957T1 (de) 1994-04-15
DK660888D0 (da) 1988-11-25
PT89053B (pt) 1993-04-30

Similar Documents

Publication Publication Date Title
EG18378A (en) Process for preparing nor-statine and nor cyclostatine polypeptides
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
EP0308873A3 (en) Ceramic composite and process for preparation thereof
HU894124D0 (en) Process for producing peptides and pharmaceutical preparatives containing these peptides
HU896774D0 (en) Process for preparation of condensated-quinoline-derivatives
HUT50121A (en) Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them
HU896728D0 (en) Process for preparation of mono-n-alkylated polyzamacrocyclides
GB8827389D0 (en) Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
HU886790D0 (en) Neutrophilous activating factor and process for its preparation
EG18596A (en) Process for the preparation of peptide structure and immunogens containing them useful in the control of fertility
ZA858412B (en) Process for the preparation and purification of peptides
PT80658B (en) Process for the preparation of amino-acids and therapeutic method thereof
EP0365970A3 (en) Process for the preparation of cyclopropanamide
ZA886908B (en) Process for preparing superconducting materials and materials thereby obtained
GB8808831D0 (en) Process for preparation of alkanediols
EP0263309A3 (en) Bromofluoroethylhypofluorite and process for its preparation
IL86277A0 (en) Process for the preparation of foreign proteins in streptomycetes
GB8806526D0 (en) Process for preparation of alkanediols
GB2217707B (en) Process for the preparation of acryloyloxyethoxymethyl-melamines
HU202557B (en) Process for producing sialinic acid-octapeptide and pharmaceutical compositions containing them
EP0324336A3 (en) Process for the preparation of 3-cyano-4-aryl-pyrroles
GB2224026B (en) Process for the preparation of 3-phenoxybenzylalcohol
EP0312922A3 (en) Oxethylsulfonyl-nitro- or -amino-benzoic acids and process for their preparation
HUT47825A (en) Sweetening preparations containing l-amino-dicarboxylacid-esters and process for producing l-amino-dicarboxylacid-esters